>> This is one of the tackiest invasions of biotech I've ever seen! Right up there with DISE. <<
BNTI was the all-time best.
THE COMPANY
The Company was incorporated in Nevada on March 4, 1987 under the name
Tome Capital Inc. The Company's name was changed to Nevada Manhattan Mining
Inc. on August 15, 1988, back to Tome Capital Inc. on July 5, 1990, to
Offshore Reliance Ltd. on February 19, 1993, to Cozy Financial Corporation on
April 20, 1993 and to BrainTech, Inc. on January 3, 1994. The Company did not carry on active business between the date of its incorporation and 1993. The
Company was registered as an extraprovincial company under the British
Columbia COMPANY ACT on January 17, 1996. The Company has one wholly owned
subsidiary, BrainWare Systems Inc., incorporated in British Columbia, Canada
on March 3, 1994.
(weird, but there's nothing pre-1999 available at Edgar??)
And then there was BFTI (wasn't that it? the company with the fluorescence instrument?) The bank account that was secured by a piece of property in San Diego? The Scottsdale guys..........
COMPANY BACKGROUND
Bio Florescent Technologies, Inc. (the "Company") is a development stage
company engaged primarily in the medical device business. The Company was
incorporated on February 15, 1990 under the laws of Nevada as Partisan
Corporation. On March 10, 1995, the Company's name was changed to Bio Florescent
Technologies, Inc. The Company was inactive through approximately January of
1995 and prior to such time the Company's only activities consisted of the sale
or transfer of shares of common stock in private placements.
sec.gov
Their last filing........
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549
FORM 12B-25
NOTIFICATION OF LATE FILING
[X] Form 10-K or Form 10-KSB [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q or Form
10-QSB [ ] Form N-SAR
For Period Ending December 31, 2000.
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended ________________
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
PART I - REGISTRANT INFORMATION
Full Name of Registrant: WHAT'S FOR FREE TECHNOLOGIES, INC.
Address of Principal 7418 East Helm Drive,
Executive Office: Scottsdale, Arizona, 85260
PART II - RULES 12B-25 (B) AND (C)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed.(Check box if appropriate)
[X] (a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without reasonable effort or expense;
(and here's one that was between those two........)
BUSINESS DEVELOPMENT:
WhatsForFree Technologies, Inc. (formerly Ranes International Holding, Inc.)
("the Company" or "we") is a development stage company that was incorporated
under the laws of the state of Nevada on February 15, 1990, as Partisan
Corporation.
1. On March 10, 1995, the Company's name was changed to Bio Fluorescent
Technologies, Inc. as it targeted the medical and health care
industry.
2. On March 6, 1998, the Company again changed its corporate name to
Ranes International Holding, Inc. and the Company broadened its search
for an industry to become a participant.
3. On December 28, 1999, the Company changed its corporate name to
WhatsForFree Technologies, Inc. ("WFFT") and is a marketing and
branding company focused on "free" products and services arena.
The Company was inactive through February 1995; prior to such time, there was no
activity other than that of capitalization efforts through the transfer of
shares of common stock in private placements.
The Company's initial business plan was based on developing, licensing or
otherwise acquiring state-of-the-art advanced diagnostic testing and screening
technology and equipment capable of early detection of human immune system
disorders such as HIV-1, HIV-2 and Hepatitis B. From February 1995 to July 1996,
the Company supported, through a license agreement, a development stage
diagnostic technology, which was settled September 25, 1997, with prejudice, to
the Company's favor. The development project costs have been written off.
In May 1996, we reorganized our management team and revised the Company's
business plan to include expansion of the Company's core market and technology
application by exploring the possibility of acquiring other technologies,
products or businesses compatible with the Company's goal to become operational
in the shortest period possible.
Up until December 1999, the Company had been vigorously pursuing industries and
other possible merger candidates. The Company has aligned itself with several
important corporate strategic partners to implement its business model, and has
attracted management and advisory teams consistent with it's business plan.
On January 17, 1998, the Company authorized a 1 for 100 reverse stock split
effective March 6, 1998. The authorized stock remained at 50,000,000 shares of
common stock. Unless otherwise indicated, the number of shares referred to in
this filing, have been restated to reflect the reverse stock split. On February
4, 1998, the Company issued 5,000,000 shares of common stock to a related
company creditor in exchange for $100,000 of accrued liability. In addition, the
Company issued 3,000,000 shares of common stock in exchange for services, and
200,000 shares of common stock for cash at $.50 a share. During 1999, the
Company issued 300,000 shares of common stock and warrants, in exchange for
services valued at $100,500. The warrants were exercisable at $4.00 per share
for two years beginning February 1, 1999. All issuances were made in accordance
with exemptions from registration pursuant to section 4(2) of the Securities Act
of 1933, as amended.
nope, sorry, the scams of today had NOTHING on the great oldies!!
Now the painful part....... I remember a market cap of over $300M for one of these. The money tucked away is funding lots of the 9/11 whoring from Scottsdale, IMO. |
